You just read:

Positive Phase 2 Study Results for Tivantinib in Previously Treated Hepatocellular Carcinoma Presented at ASCO

News provided by

ArQule, Inc.& Daiichi Sankyo Company, Limited

11 Jun, 2012, 09:00 BST